Maxele Advisors, LLC
- SEC CIK
- 0002096567
- Latest filing
- Aug 14, 2026
PFE holding history
Pfizer Inc in every 13F filed by Maxele Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −7,714−100.0% | Sold out | Holders |
| Q4 2024 | 7,714 | $204.7K | 0.2% | – | No prior filing | Holders |
| Q4 2022 | – | – | – | – | Not filed | Holders |
| Q3 2022 | 8,535 | $373.5K | 0.6% | −19−0.2% | Reduced | Holders |
| Q2 2022 | 8,554 | $448.5K | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2022 | 8,554 | $442.8K | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2021 | 8,554 | $505.1K | 0.6% | – | No prior filing | Holders |